In an experimental model for the treatment of Krabbe’s disease, Katona and colleagues showed that the life span was increased in chimeric model mice when wild-type ES cells with a SATAC containing the human GALC gene was microinjected into the model mouse-derived blastocysts. Here, GALC is linked to Krabbe disease.